Verhagen OJ - Search Results

1

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.

Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJ. Pongers-Willemse MJ, et al. Among authors: verhagen oj. Leukemia. 1998 Dec;12(12):2006-14. doi: 10.1038/sj.leu.2401246. Leukemia. 1998. PMID: 9844931

2

Detection of circulating breast tumor cells by differential expression of marker genes.

Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AA, Rodenhuis S, van 't Veer LJ. Bosma AJ, et al. Among authors: verhagen oj. Clin Cancer Res. 2002 Jun;8(6):1871-7. Clin Cancer Res. 2002. PMID: 12060630

3

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group.

Willems P, Verhagen O, Segeren C, Veenhuizen P, Guikema J, Wiemer E, Groothuis L, Jong TB, Kok H, Bloem A, Bos N, Vellenga E, Mensink E, Sonneveld P, Lokhorst H, van Der Schoot E, Raymakers R. Willems P, et al. Blood. 2000 Jul 1;96(1):63-70. Blood. 2000. PMID: 10891431 Free article.

4

The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia.

de Haas V, Breunis WB, Dee R, Verhagen OJ, Kroes W, van Wering ER, van Dongen JJ, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: verhagen oj. Br J Haematol. 2002 Jan;116(1):87-93. doi: 10.1046/j.1365-2141.2002.03228.x. Br J Haematol. 2002. PMID: 11841400

5

Accurate quantification of minimal residual disease at day 15, by real-time quantitative polymerase chain reavtion identifies also patients with B-precursor acute lymphoblastic leukemia at high risk for relapse.

de Haas V, Breunis WB, Verhagen OJ, van der Berg H, van der Schoot CE. de Haas V, et al. Among authors: verhagen oj. Blood. 2000 Aug 15;96(4):1619-20. Blood. 2000. PMID: 10979670 Free article. No abstract available.

6

Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques.

Verhagen OJ, Wijkhuijs AJ, van der Sluijs-Gelling AJ, Szczepański T, van der Linden-Schrever BE, Pongers-Willemse MJ, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Leukemia. 1999 Aug;13(8):1298-9. doi: 10.1038/sj.leu.2401451. Leukemia. 1999. PMID: 10450765 No abstract available.

7

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.

Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Leukemia. 2000 Aug;14(8):1426-35. doi: 10.1038/sj.leu.2401801. Leukemia. 2000. PMID: 10942239

8

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.

de Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: verhagen oj. Leukemia. 2001 Jan;15(1):134-40. doi: 10.1038/sj.leu.2401970. Leukemia. 2001. PMID: 11243381

9

Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.

de Haas V, Oosten L, Dee R, Verhagen OJ, Kroes W, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: verhagen oj. Br J Haematol. 2000 Dec;111(4):1080-6. doi: 10.1046/j.1365-2141.2000.02434.x. Br J Haematol. 2000. PMID: 11167743

10

Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, Behrendt H, Slater RR, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: verhagen oj. Leukemia. 1997 Aug;11(8):1258-65. doi: 10.1038/sj.leu.2400720. Leukemia. 1997. PMID: 9264379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results